Author Archives: Yves Smith

Purdue Pharma’s OxyContin: Corporate Fraud With a Body Count

Yves here. Some of the facts in this article are stunning. For instance, more Americans die from opoid overdose than from car accidents. And this article gives only a partial tally of Purdue Pharma’s predatory conduct. The drugmaker targeted overly-busy, not very well trained general practitioners in communities which were likely to have high incidence […]

Read more...

Unsealed Documents Reveal Former White House Officials Violated Fannie/Freddie Conservatorship Rules, Apparently to Advance Bank-Enriching “Reforms”

The Administration has refused to turn over over 12,000 documents in a lawsuit against how the government operated Fannie and Freddie in their conservatorship. The major bone of contention is that Treasury stripped them of all profits, which damaged the remaining private shareholders. But the unsealing of a small batch of government records shows why […]

Read more...

SEC Official Defends Weak, Selective Enforcement When Agency Records Show Private Equity Firms Thumb Nose at Agency

Yesterday, we looked at a section of a Stanford Law School conference at the end of March. The panel on pre-IPO funding included the SEC/s head of enforcement, Andrew Ceresney. In the question and answer section, Ceresney and a member of the audience, Marc Fagel, the former regional director of the SEC’s San Francisco office, […]

Read more...

Inflation Targeting and Neoliberalism, Part 3

Yves here. In a bit of synchronicity, this post continues the theme of Dipherio’s podcast over the weekend on NAIRU, describing how other central banks around the world look at the issue of what inflation rate to try to achieve and why. I’m a little surprised that Epstein did not mention how the Fed kept […]

Read more...